Amgen Inc: (NASD: AMGN)

(U.S: NASD) As of Apr 21 03:59 PM ET

 Add to portfolio

$115.46 USD

-0.08 (-0.07%)

Volume: 3,237,732

Zacks Rank : 1-Strong Buy [?] #1        

Brokerage Reports

Search for reports:

0 items in cart

AMGEN INC [AMGN]

Reports for Purchase

Showing records 1 - 20 ( 172 total )

Company: AMGEN INC

Industry: MED-BIOMED/GENE

Record: 1

03/19/2014

Industry Report

Pages: 6

February Script Data Tempered by Fewer Selling Days

Provider: Robert W. Baird & Co., Inc.

Analyst: RAYMOND C

Price: 25.00

Company: AMGEN INC

Industry: MED-BIOMED/GENE

Record: 2

02/28/2014

Company Report

Pages: 10

Price: 24.95

Research Provided by a Third Party

Company: AMGEN INC

Industry: MED-BIOMED/GENE

Record: 3

01/30/2014

Company Report

Pages: 9

Price: 24.95

Research Provided by a Third Party

Company: AMGEN INC

Industry: MED-BIOMED/GENE

Record: 4

01/29/2014

Financial Spreadsheet

Pages: 24

Model.

Provider: Nomura

Analyst: SOMAIYA M

Price: .00

Company: AMGEN INC

Industry: MED-BIOMED/GENE

Record: 5

01/29/2014

Company Report

Pages: 8

One-Timers Once Again; Guidance Just Okay

Provider: Robert W. Baird & Co., Inc.

Analyst: RAYMOND C

Price: 25.00

Company: AMGEN INC

Industry: MED-BIOMED/GENE

Record: 6

01/28/2014

Company Report

Pages: 10

4Q13 Beat Not Followed by a Raise

Provider: Nomura

Analyst: SOMAIYA M

Price: 25.00

Company: AMGEN INC

Industry: MED-BIOMED/GENE

Record: 7

01/23/2014

Company Report

Pages: 5

Another Positive P3 Readout for Evolocumab

Provider: Nomura

Analyst: SOMAIYA M

Price: 10.00

Company: AMGEN INC

Industry: MED-BIOMED/GENE

Record: 8

01/15/2014

Financial Spreadsheet

Pages: 24

Model.

Provider: Nomura

Price: .00

Research Provided by a Third Party

Company: AMGEN INC

Industry: MED-BIOMED/GENE

Record: 9

01/13/2014

Company Report

Pages: 8

Reducing Estimates to Reflect Higher SG&A

Provider: Nomura

Price: 25.00

Research Provided by a Third Party

Company: AMGEN INC

Industry: MED-BIOMED/GENE

Record: 10

01/09/2014

Financial Spreadsheet

Pages: 24

Model.

Provider: Nomura

Price: .00

Research Provided by a Third Party

Company: AMGEN INC

Industry: MED-BIOMED/GENE

Record: 11

01/09/2014

Daily Note

Pages: 14

Previewing 4Q13 and 2014 Guidance

Provider: Nomura

Price: 50.00

Research Provided by a Third Party

Company: AMGEN INC

Industry: MED-BIOMED/GENE

Record: 12

01/07/2014

Company Report

Pages: 46

Initiating with Neutral Rating and $131 TP

Provider: Nomura

Price: 100.00

Research Provided by a Third Party

Company: AMGEN INC

Industry: MED-BIOMED/GENE

Record: 13

01/07/2014

Daily Note

Pages: 360

Initiating on US Biotechnology Sector

Provider: Nomura

Price: 150.00

Research Provided by a Third Party

Company: AMGEN INC

Industry: MED-BIOMED/GENE

Record: 14

12/30/2013

Company Report

Pages: 10

Price: 24.95

Research Provided by a Third Party

Company: AMGEN INC

Industry: MED-BIOMED/GENE

Record: 15

12/23/2013

Industry Report

Pages: 5

Biotechnology - November Monthly Institutional Data Posts a Little Earlier Than Expected

Provider: Robert W. Baird & Co., Inc.

Price: 10.00

Research Provided by a Third Party

Company: AMGEN INC

Industry: MED-BIOMED/GENE

Record: 16

12/20/2013

Company Report

Pages: 9

New Survey Indicates EPO Still Hasn?t Found a Bottom

Provider: Robert W. Baird & Co., Inc.

Analyst: RAYMOND C

Price: 25.00

Company: AMGEN INC

Industry: MED-BIOMED/GENE

Record: 17

12/06/2013

Industry Report

Pages: 8

ASH Setting Up as a Largely Positive Event

Provider: Robert W. Baird & Co., Inc.

Analyst: RAYMOND C

Price: 25.00

Company: AMGEN INC

Industry: MED-BIOMED/GENE

Record: 18

11/26/2013

Company Report

Pages: 9

FDA Safety Data Doesn?t Indict Kyprolis; but Full Pardon Still Elusive

Provider: Robert W. Baird & Co., Inc.

Analyst: RAYMOND C

Price: 25.00

Company: AMGEN INC

Industry: MED-BIOMED/GENE

Record: 19

11/20/2013

Industry Report

Pages: 6

Just One Month, But October Script Data Provides No Major Surprises

Provider: Robert W. Baird & Co., Inc.

Analyst: RAYMOND C

Price: 25.00

Company: AMGEN INC

Industry: MED-BIOMED/GENE

Record: 20

10/24/2013

Company Report

Pages: 10

Price: 24.95

Research Provided by a Third Party